Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von ElectricPlayer 

Zoetis Inc. A diskutieren

Zoetis Inc. A

WKN: A1KBYX / Symbol: ZTS / Name: Zoetis / Aktie / Pharmazeutika / Large Cap /

106,40 €
0,51 %

Einschätzung Buy
Rendite (%) -34,94 %
Kursziel 233,16
Veränderung
Endet am 29.01.26

Zoetis Inc. (NYSE: ZTS) had its price target lowered by analysts at Morgan Stanley from $248.00 to $243.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -36,38 %
Kursziel 193,80
Veränderung
Endet am 10.02.26

Zoetis Inc. (NYSE: ZTS) had its price target lowered by analysts at Piper Sandler from $210.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -29,55 %
Kursziel 226,65
Veränderung
Endet am 14.02.26

Zoetis Inc. (NYSE: ZTS) had its price target lowered by analysts at Morgan Stanley from $243.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -29,80 %
Kursziel 232,26
Veränderung
Endet am 14.02.26

Zoetis Inc. (NYSE: ZTS) had its price target raised by analysts at Barclays PLC from $242.00 to $244.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -32,53 %
Kursziel 196,62
Veränderung
Endet am 27.02.26

Zoetis Inc. (NYSE: ZTS) had its price target raised by analysts at Piper Sandler from $200.00 to $205.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,83 %
Kursziel 144,90
Veränderung
Endet am 14.04.26

Zoetis Inc. (NYSE: ZTS) had its price target lowered by analysts at Stifel Nicolaus from $180.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -27,74 %
Kursziel 187,07
Veränderung
Endet am 12.05.26

Zoetis Inc. (NYSE: ZTS) had its price target raised by analysts at Piper Sandler from $205.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -16,50 %
Kursziel 184,32
Veränderung
Endet am 11.08.26

Zoetis Inc. (NYSE: ZTS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $215.00 price target on the stock, up previously from $210.00.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,20 %
Kursziel 161,39
Veränderung
Endet am 09.09.26

Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at Argus. They now have a $190.00 price target on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,33 %
Kursziel 174,02
Veränderung
Endet am 05.11.26

Zoetis (NYSE:ZTS) had its price target lowered by analysts at JPMorgan Chase & Co. from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,70 %
Kursziel 151,41
Veränderung
Endet am 10.11.26

Zoetis (NYSE:ZTS) had its price target lowered by analysts at Morgan Stanley from $211.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,72 %
Kursziel 138,21
Veränderung
Endet am 12.11.26

Zoetis (NYSE:ZTS) had its price target lowered by analysts at BTIG Research from $200.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for ZTS provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,15 %
Kursziel 137,49
Veränderung
Endet am 03.12.26

Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
Ratings data for ZTS provided by MarketBeat

Zoetis (NYSE:ZTS) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "buy" rating.
Ratings data for ZTS provided by MarketBeat